rs1060619

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002046.7(GAPDH):​c.29+754T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.276 in 246,346 control chromosomes in the GnomAD database, including 10,945 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.31 ( 8385 hom., cov: 32)
Exomes 𝑓: 0.23 ( 2560 hom. )

Consequence

GAPDH
NM_002046.7 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.180

Publications

15 publications found
Variant links:
Genes affected
GAPDH (HGNC:4141): (glyceraldehyde-3-phosphate dehydrogenase) This gene encodes a member of the glyceraldehyde-3-phosphate dehydrogenase protein family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. The product of this gene catalyzes an important energy-yielding step in carbohydrate metabolism, the reversible oxidative phosphorylation of glyceraldehyde-3-phosphate in the presence of inorganic phosphate and nicotinamide adenine dinucleotide (NAD). The encoded protein has additionally been identified to have uracil DNA glycosylase activity in the nucleus. Also, this protein contains a peptide that has antimicrobial activity against E. coli, P. aeruginosa, and C. albicans. Studies of a similar protein in mouse have assigned a variety of additional functions including nitrosylation of nuclear proteins, the regulation of mRNA stability, and acting as a transferrin receptor on the cell surface of macrophage. Many pseudogenes similar to this locus are present in the human genome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.484 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GAPDHNM_002046.7 linkc.29+754T>C intron_variant Intron 2 of 8 ENST00000229239.10 NP_002037.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GAPDHENST00000229239.10 linkc.29+754T>C intron_variant Intron 2 of 8 1 NM_002046.7 ENSP00000229239.5

Frequencies

GnomAD3 genomes
AF:
0.306
AC:
46401
AN:
151834
Hom.:
8357
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.489
Gnomad AMI
AF:
0.236
Gnomad AMR
AF:
0.282
Gnomad ASJ
AF:
0.175
Gnomad EAS
AF:
0.489
Gnomad SAS
AF:
0.262
Gnomad FIN
AF:
0.273
Gnomad MID
AF:
0.180
Gnomad NFE
AF:
0.203
Gnomad OTH
AF:
0.260
GnomAD4 exome
AF:
0.227
AC:
21448
AN:
94394
Hom.:
2560
AF XY:
0.226
AC XY:
10264
AN XY:
45336
show subpopulations
African (AFR)
AF:
0.504
AC:
844
AN:
1676
American (AMR)
AF:
0.433
AC:
39
AN:
90
Ashkenazi Jewish (ASJ)
AF:
0.166
AC:
93
AN:
560
East Asian (EAS)
AF:
0.506
AC:
179
AN:
354
South Asian (SAS)
AF:
0.276
AC:
537
AN:
1948
European-Finnish (FIN)
AF:
0.184
AC:
7
AN:
38
Middle Eastern (MID)
AF:
0.129
AC:
25
AN:
194
European-Non Finnish (NFE)
AF:
0.219
AC:
18899
AN:
86474
Other (OTH)
AF:
0.270
AC:
825
AN:
3060
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
823
1645
2468
3290
4113
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
902
1804
2706
3608
4510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.306
AC:
46477
AN:
151952
Hom.:
8385
Cov.:
32
AF XY:
0.308
AC XY:
22840
AN XY:
74262
show subpopulations
African (AFR)
AF:
0.489
AC:
20261
AN:
41402
American (AMR)
AF:
0.282
AC:
4300
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.175
AC:
608
AN:
3470
East Asian (EAS)
AF:
0.489
AC:
2526
AN:
5164
South Asian (SAS)
AF:
0.260
AC:
1253
AN:
4818
European-Finnish (FIN)
AF:
0.273
AC:
2890
AN:
10570
Middle Eastern (MID)
AF:
0.173
AC:
51
AN:
294
European-Non Finnish (NFE)
AF:
0.203
AC:
13819
AN:
67960
Other (OTH)
AF:
0.264
AC:
554
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1546
3092
4639
6185
7731
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
442
884
1326
1768
2210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.242
Hom.:
11075
Bravo
AF:
0.316
Asia WGS
AF:
0.425
AC:
1476
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
8.7
DANN
Benign
0.72
PhyloP100
-0.18
PromoterAI
0.048
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1060619; hg19: chr12-6644781; API